fig1

From: Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated vs. stereotactic body radiotherapy

$Prognostic value of lymphocyte subset levels in hepatocellular carcinoma following conventionally fractionated <i>vs</i>. stereotactic body radiotherapy$

Figure 1. Impacts of different RT modalities on lymphocyte subset levels in patients with HCC. The absolute counts of TPLC, CD19+ B cells, NK cells, CD4+ T cells, and CD8+ T cells, as well as the CD4+/CD8+ ratio, were measured at baseline (within 1 week prior to RT) and at subsequent time points post-RT (1 day and 2 months). Statistically significant differences are indicated by ^*P < 0.05, ^**P < 0.01, ^***P < 0.001, and ^****P < 0.0001. RT: Radiotherapy; HCC: hepatocellular carcinoma; TPLC: total peripheral lymphocytes; CFRT: conventionally fractionated radiotherapy; SBRT: stereotactic body radiotherapy.